Establishment of xenografts of urological cancers on chicken chorioallantoic membrane (CAM) to study metastasis.

animal mode bladder cancer chorioallantoic membrane kidney cancer prostate cancer

Journal

Precision clinical medicine
ISSN: 2516-1571
Titre abrégé: Precis Clin Med
Pays: England
ID NLM: 101739592

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 11 07 2019
revised: 23 08 2019
accepted: 26 08 2019
entrez: 11 10 2019
pubmed: 11 10 2019
medline: 11 10 2019
Statut: ppublish

Résumé

Cancer of the urological system commonly occurs in the kidney, bladder, and prostate gland. The clear cell subtype of renal cell carcinoma (ccRCC) constitutes the great majority of kidney cancer. Metastatic ccRCC portends a very poor outcome with no effective treatment available. Prostate cancer is the most common cancer in males in the US. Despite recent advances in selective kinase inhibitors and immunotherapies, the rate of developing new treatment from bench to bedside is slow. A time-consuming step is at the animal drug testing stage, in which the mouse model is the gold standard. In the pursuit to streamline the

Identifiants

pubmed: 31598385
doi: 10.1093/pcmedi/pbz018
pii: pbz018
pmc: PMC6770283
doi:

Types de publication

Journal Article

Langues

eng

Pagination

140-151

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016042
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA216770
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001881
Pays : United States

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of West China School of Medicine & West China Hospital of Sichuan University.

Références

Cancer Lett. 2007 Jan 8;245(1-2):127-33
pubmed: 16516376
Sci Rep. 2016 Jun 30;6:29032
pubmed: 27358011
Cell. 1994 Dec 30;79(7):1157-64
pubmed: 7528107
Int J Urol. 2017 Oct;24(10):735-742
pubmed: 28636222
Nat Protoc. 2016 May;11(5):937-48
pubmed: 27101515
Sci Transl Med. 2012 Jun 6;4(137):137ra75
pubmed: 22674553
Ann Oncol. 2012 Apr;23(4):973-80
pubmed: 21890909
Front Oncol. 2019 May 09;9:385
pubmed: 31143708
Int J Mol Sci. 2012;13(8):9959-70
pubmed: 22949841
Cancer Res. 2017 Nov 1;77(21):5977-5988
pubmed: 28916657
PLoS One. 2018 Jan 22;13(1):e0190854
pubmed: 29357370
J Vis Exp. 2011 May 30;(51):null
pubmed: 21673636
Cell. 1987 Nov 6;51(3):503-12
pubmed: 2822260
Int J Oncol. 1998 Jul;13(1):17-21
pubmed: 9625798
Nat Commun. 2017 Apr 24;8:15059
pubmed: 28436416
J Urol. 2016 Mar;195(3):771-9
pubmed: 26318986
Transl Androl Urol. 2019 May;8(Suppl 2):S156-S165
pubmed: 31236333
J Transl Med. 2019 Apr 15;17(1):125
pubmed: 30987640
Cell Tissue Bank. 2017 Sep;18(3):425-431
pubmed: 28258397
Sci Rep. 2018 Jun 4;8(1):8524
pubmed: 29867159
PLoS One. 2019 Apr 15;14(4):e0215312
pubmed: 30986223
Stem Cell Reports. 2017 Aug 8;9(2):464-477
pubmed: 28793246
Science. 1931 Oct 9;74(1919):371-2
pubmed: 17810781
Clin Exp Metastasis. 2009;26(8):1033-47
pubmed: 19842048
J Vis Exp. 2013 Jul 17;(77):e50522
pubmed: 23892612
Nature. 2016 Sep 14;537(7620):S97
pubmed: 27626782
In Vivo. 2019 Jan-Feb;33(1):41-46
pubmed: 30587600
Prostate. 2017 Jan;77(1):10-21
pubmed: 27550065
Anticancer Res. 2015 Dec;35(12):6521-8
pubmed: 26637866
Nat Med. 2002 Aug;8(8):891-7
pubmed: 12134144
J Cutan Pathol. 2009 Dec;36(12):1237-43
pubmed: 19469865
In Vivo. 2013 Nov-Dec;27(6):701-5
pubmed: 24292571
Food Chem Toxicol. 1994 Dec;32(12):1155-60
pubmed: 7813987
Cancer Sci. 2008 Jan;99(1):39-45
pubmed: 17970783
Science. 1938 Oct 21;88(2286):384-5
pubmed: 17746419
J Pharmacol Exp Ther. 2015 Jan;352(1):33-42
pubmed: 25316122
Mol Ther Methods Clin Dev. 2018 Feb 23;9:203-210
pubmed: 29766028
Angiogenesis. 2014 Oct;17(4):779-804
pubmed: 25138280
Angiogenesis. 2013 Jan;16(1):181-94
pubmed: 23076651
J Natl Cancer Inst. 2013 Apr 3;105(7):452-8
pubmed: 23434901
In Vitro Cell Dev Biol Anim. 1998 Jul-Aug;34(7):537-44
pubmed: 9719413
Lasers Med Sci. 1999 Jun;14(2):91-6
pubmed: 24519162
Cancer Res. 2011 Oct 1;71(19):6250-60
pubmed: 21933883
Nihon Hinyokika Gakkai Zasshi. 1989 Dec;80(12):1749-54
pubmed: 2625822
Br J Cancer. 2014 Nov 25;111(11):2103-13
pubmed: 25349966
J Anat. 2003 Sep;203(3):323-8
pubmed: 14529049

Auteurs

Junhui Hu (J)

Department of Molecular and Medical Pharmacology.

Moe Ishihara (M)

Department of Molecular and Medical Pharmacology.

Arnold I Chin (AI)

Department of Urology.
Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California at Los Angeles, CA 90095, USA.

Lily Wu (L)

Department of Molecular and Medical Pharmacology.
Department of Urology.
Department of Pediatrics.
Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California at Los Angeles, CA 90095, USA.

Classifications MeSH